PEMT Genotype

Two people can eat the same diet, drink the same amount, and live the same lifestyle, yet one ends up with fatty liver while the other does not. A portion of that difference comes down to genes that control how efficiently your body makes phosphatidylcholine, a fat-like molecule your liver needs to package and ship out triglycerides. PEMT (phosphatidylethanolamine N-methyltransferase) is one of those genes.

Common variants in PEMT change how much choline you actually need, how your liver handles fat, and how your body distributes weight. Knowing your genotype can explain why a friend tolerates a low-choline diet and you don't, or why your liver enzymes drift up even when your weight and cholesterol look fine.

What PEMT Actually Does

PEMT is the gene that codes for an enzyme expressed primarily in your liver that converts one phospholipid (phosphatidylethanolamine) into another (phosphatidylcholine), the most abundant phospholipid in cell membranes and a key component of the fat-shuttling particles your liver releases into the blood. This pathway is one of two ways your body gets phosphatidylcholine. The other depends entirely on the choline you eat. If your PEMT pathway runs slow because of a genetic variant, your dietary choline requirement goes up.

Estrogen normally turns the PEMT enzyme on, which is one reason premenopausal women have lower dietary choline needs than men or postmenopausal women. Several common PEMT variants disrupt this estrogen-driven boost, leaving carriers with reduced enzyme activity and a higher dependency on choline from food.

Choline Deficiency Risk in Women

The variant rs12325817 sits near a stretch of DNA that responds to estrogen. The risk allele prevents the estrogen receptor and a partner protein (FOXA1) from binding properly, blunting the normal hormonal boost to PEMT activity. In premenopausal women fed a low-choline diet, the consequences are dose-dependent: 80% of women carrying two risk alleles developed signs of organ dysfunction, compared with 43% of those with one risk allele and just 13% of women with no risk alleles.

Direct measurements in human liver tissue confirm that women homozygous for this variant have lower PEMT enzyme activity and lower levels of DHA-containing phosphatidylcholine, an omega-3-rich form of the molecule that is hardest to make through the dietary pathway alone.

Fatty Liver and NASH

A separate variant called V175M (rs7946) produces a less active version of the PEMT enzyme. In a Japanese case-control study comparing 107 patients with biopsy-confirmed nonalcoholic steatohepatitis (NASH), the inflamed form of fatty liver disease, with 150 healthy controls, the variant allele was significantly more common in NASH patients. Non-obese NASH was particularly enriched among carriers, suggesting this variant helps explain liver disease in people whose BMI looks unremarkable.

In a Taiwanese study of 250 older adults with metabolic disorders, the rs7946 A allele was linked to lower hepatic steatosis risk and lower BMI in both sexes, with the protective effect of adequate choline intake depending on both sex and genotype. The direction of effect for rs7946 is not consistent across populations. A meta-analysis pooling multiple cohorts found the A allele was associated with higher NAFLD risk overall, so the protective signal in the Taiwanese cohort may reflect population-specific gene-diet interactions rather than a universal effect. Hepatic PEMT expression also drops as fatty liver disease worsens, with the steepest declines in obese individuals and postmenopausal women.

Body Composition and Diabetes

Variants near PEMT (rs4646404 and rs4646343) have been linked to waist-to-hip ratio, BMI, and visceral fat area in a cohort of 3,564 people. These same variants change how much PEMT is expressed in fat tissue, suggesting the gene plays a role in where your body stores fat, not just how much.

In a Chinese study of 372 people with diabetes, the GG genotype of the G774C variant, combined with high homocysteine and low betaine, was linked to higher risk of microangiopathy (damage to small blood vessels). The CC genotype carried lower risk of diabetes and its vascular complications compared with GG.

Fertility and Reproductive Effects

In a study of 450 men (200 with low sperm counts and 250 with normal counts), those with the 774G/G genotype had higher sperm concentrations than carriers of the C allele. A separate Swedish case-control study of 337 men (153 with infertility and 184 controls) linked the V175M variant to idiopathic male infertility. These findings position PEMT as one of several genes that may contribute to unexplained fertility issues, especially in men whose standard semen parameters are borderline.

DHA and Omega-3 Status

Because the PEMT pathway is the primary way your body builds DHA-rich phosphatidylcholine, variants in this gene affect how efficiently you incorporate omega-3 fats. In pregnancy, carriers of the rs4646343 variant tended to have lower DHA in both maternal and cord red blood cells. In obese children, the rs1109859 variant was linked to differences in red blood cell DHA and EPA independent of how much omega-3 the children consumed.

Digestive Cancers

In a nested case-control study of 1,151 people in China, the wild-type CC genotype of rs7946 was associated with higher risk of digestive system cancer than CT or TT genotypes. About 13.55% of this risk association was mediated by the plasma choline-to-betaine ratio, suggesting genotype interacts with one-carbon metabolism to shape cancer risk.

What This Test Cannot Tell You

PEMT genotyping reports the variants you inherited at specific positions in this gene. It does not directly measure your current liver function, your choline status, or whether fatty liver is present right now. The genotype shifts the odds and the dietary thresholds that apply to you. It does not deliver a diagnosis. All current evidence is observational. No clinical trial has shown that screening healthy adults for PEMT variants improves outcomes, and there are no standardized clinical cutpoints for interpreting individual results.

One-Time Result

Your PEMT genotype is fixed at conception. The result you get at age 30 will be identical at age 60. There is no value in repeating this test once you have a reliable genotype call, unless the original assay had quality issues or a different method is needed to confirm an unexpected finding.

What does need ongoing monitoring is the downstream picture. If your genotype suggests higher choline needs or higher fatty liver susceptibility, your liver enzymes (ALT, AST, GGT), lipid panel, fasting insulin, and waist circumference become the numbers worth tracking annually. For women approaching or past menopause, that monitoring matters more because the estrogen-driven boost to PEMT activity drops.

What an Unexpected Result Should Make You Do

If you carry a higher-risk PEMT variant, the practical next steps are workup and ongoing surveillance, not a panic response. The most informative companion tests are a liver panel (ALT, AST, GGT, ALP), fasting lipid panel with ApoB, fasting insulin and glucose, and homocysteine. If your liver enzymes are drifting up or your waist circumference is rising, a liver imaging study (ultrasound or FibroScan) becomes reasonable, especially if you carry V175M or rs12325817 risk alleles.

For women approaching menopause, an earlier conversation about choline-rich foods and monitoring liver function becomes more important. For men with borderline semen analyses, PEMT genotype may help explain otherwise unexplained findings and is worth sharing with a fertility specialist. A consultation with a genetic counselor or a clinician familiar with nutrigenetics can help integrate the genotype into the rest of your health picture.

Limitations to Keep in Mind

PEMT is not a Tier 1 clinical test. There are no guideline-endorsed cutpoints, no consensus on which variants to report, and no outcome trials showing that genotype-guided care improves long-term health. The size of the effects in published studies is real but moderate, and most associations come from observational research in specific populations (Japanese, Chinese, European). The direction of effect for some variants, including rs7946, even varies across populations, so individual study findings should not be over-interpreted. Whether the same effect sizes apply to your ancestry depends on which variants the assay covers and how common they are in your background population.

Variant panel coverage matters. A negative result means the panel did not find the specific variants it was designed to detect, not that you carry no risk variants anywhere in the gene. If a direct-to-consumer test reported your PEMT status, the depth and accuracy of those results can differ from clinical-grade sequencing.